A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 12,870 shares of EXAS stock, worth $680,951. This represents 0.25% of its overall portfolio holdings.

Number of Shares
12,870
Previous 12,870 -0.0%
Holding current value
$680,951
Previous $544 Million 61.23%
% of portfolio
0.25%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$41.33 - $74.26 $154,367 - $277,361
3,735 Added 40.89%
12,870 $544 Million
Q1 2024

May 13, 2024

BUY
$56.27 - $73.77 $123,512 - $161,925
2,195 Added 31.63%
9,135 $631 Million
Q4 2023

Feb 09, 2024

BUY
$59.06 - $75.72 $65,556 - $84,049
1,110 Added 19.04%
6,940 $513 Million
Q3 2023

Nov 08, 2023

BUY
$65.94 - $99.04 $384,430 - $577,403
5,830 New
5,830 $398 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.36B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Annis Gardner Whiting Capital Advisors, LLC Portfolio

Follow Annis Gardner Whiting Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Annis Gardner Whiting Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annis Gardner Whiting Capital Advisors, LLC with notifications on news.